A Prospective Trial to Assess Breast Cancer Survivors and Vaginal Atrophy Treatment Outcomes

Key Inclusion Criteria: * 18 years or older * Breast cancer survivors defined as women with a history of hormone sensitive breast cancer on tamoxifen * Self-reported vaginal laxity * Meet diagnosis of sexual dysfunction * Patients must be able to understand and willing to sign a written informed consent document and be willing to complete the patient reported outcome tools at the scheduled time points Exclusion Criteria: * Cognitive impairment * Women currently on chemotherapy and/or radiation or who have had their last chemotherapy within 6 months of the intervention * Women with active breast cancer disease * Women currently on hormone therapy or who are pregnant * Women who have had vaginal or pelvic surgery involving the genitalia